Vancomycin Trough Dose Calculator
Vancomycin dosing uses one-compartment pharmacokinetics. Clearance (CL) is estimated from renal function. Using a target trough concentration (Css,trough) and knowing the dosing interval (tau), the estimated dose can be calculated: Dose = CL x Css,avg x tau / F. The average steady-state concentration is approximated from the trough and the elimination during the dosing interval. Note that current clinical practice favors AUC-guided monitoring over trough-only monitoring per the 2020 ASHP/IDSA/SIDP guidelines. This calculator illustrates trough-based estimation for educational purposes.
Vancomycin trough-based dose estimation
ke = CL / Vd
Css,avg = Css,trough / e^(-ke x tau) x (1 - e^(-ke x tau)) / (ke x tau)
Dose = CL x Css,avg x tau
CL in L/hr; Vd in L; tau in hr; Css,trough target in mg/L. This is a simplified trough-based model. Modern AUC-guided vancomycin monitoring using Bayesian software is preferred per current ASHP/IDSA/SIDP guidelines.
Vancomycin pharmacokinetic principles
- Vancomycin follows one-compartment kinetics in most patients; two-compartment modeling may be needed in critically ill patients.
- CL estimation: approximately 0.8 x CrCl (mL/min) x 0.06 = CL (L/hr); adjusted for non-renal clearance.
- AUC24/MIC target of 400 to 600 (assuming MIC 1 mg/L for MRSA) is the current guideline-recommended endpoint.
- Nephrotoxicity risk increases with trough above 20 mg/L and with prolonged therapy; AUC-guided dosing reduces this risk.
- Always round to the nearest practical dose (usually 250 mg increment) and infuse over at least 1 hour to prevent red man syndrome.
Vancomycin trough dose: frequently asked questions
What is vancomycin trough monitoring?
Vancomycin trough concentration is measured immediately before the next dose and historically was the primary pharmacokinetic target. Target troughs of 10 to 15 mg/L for most infections and 15 to 20 mg/L for serious infections (MRSA pneumonia, endocarditis, meningitis) were recommended. AUC-guided monitoring is now preferred per 2020 ASHP/IDSA/SIDP guidelines.
What is AUC-guided vancomycin monitoring?
The 2020 ASHP/IDSA/SIDP Vancomycin Consensus Guidelines recommend targeting a daily AUC/MIC of 400 to 600 mg x hr/L (assuming MIC = 1 mg/L for MRSA) rather than trough alone. AUC-guided dosing reduces nephrotoxicity while maintaining efficacy. Bayesian programs or two-sample PK methods are used.
What factors affect vancomycin clearance?
Vancomycin is predominantly renally eliminated. Clearance correlates with creatinine clearance (CrCl). Obesity, critical illness, augmented renal clearance, and dialysis all significantly alter vancomycin pharmacokinetics and require individualized dosing and monitoring.
What is the typical volume of distribution for vancomycin?
Vancomycin Vd is approximately 0.5 to 1.0 L/kg. Critically ill patients, burn patients, and those with edema may have significantly expanded Vd. Obese patients may require weight-based Vd estimation using adjusted body weight.
Can this calculator be used for clinical vancomycin dosing?
No. This tool is for educational and pharmacokinetic learning purposes only. Clinical vancomycin dosing requires patient-specific pharmacokinetic assessment, therapeutic drug monitoring (AUC preferred), clinical pharmacist review, and physician oversight following current guidelines.
Official sources
- ASHP/IDSA/SIDP: Vancomycin Therapeutic Monitoring Consensus Guidelines (2020).
- NIH National Library of Medicine: Vancomycin (StatPearls).
Reviewed by the CalculatorHub team, edited by James Graham, 15 June 2026. See our methodology.